Medical Simulation Medical Graphic
Medical Animation | MOA | Medical Illustration | Holo 3D | General 3D | Video Game Development | Contact

Biotechnology Animations – Biotechnology Illustrations

Clinical Animations / Trial Animations

Clinical Studies Animated Method of Action Video

Medical Animation Studio produces clinical animations and clinical illustrations.  Custom 3d trail illustrations and clinical illustrations for e learning can also be produced.   Biotechnology animations and biotechnology illustrations created for biotech companies and biotechnology marketing companies.
Biotechnology animated method of action video. 
Dr Nano
Positive top line results announced for inhaled anti-RSV nanobody (alx-0171) in a phase I/IIa study in infants
Ablynx has announced positive top line results from the first-in-infant Phase I/IIa study of its wholly-owned, inhaled, anti-RSV Nanobody, ALX-0171, in 53 infants, aged 1-24 months, hospitalised as...
Ebola vaccine: Promising phase I trials
"The results for tolerability, safety, and the immune response to the vaccine candidate are very promising," explains Prof Marylyn Addo.
12-month data highlight the safety and efficacy of ab-interno canaloplasty in primary open-angle glaucoma
Ellex Medical Lasers Ltd is pleased to announce findings from a 12-month case series review of 228 patients with primary open-angle glaucoma (POAG) which show that ab-interno canaloplasty (ABiC)...
NightstaRx reports long-term benefits of gene therapy for inherited form of progressive blindness
NightstaRx Ltd, a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, today announced the publication from the University of Oxford of promising...
Massive failure to publish trial results exposes patients to risks without providing benefits for others
Although the publication of results of clinical trials carried out in the US within 12 months of their completion has been mandatory since 2007, an astoundingly high number of Phase III radiotherapy...
Scientists teaching machines to make clinical trials more successful
Scientists are teaching computers to figure out why people accept or decline invitations to participate in clinical trials.
Multiple myeloma: Phase 3 trial results for the oral proteasome inhibitor ixazomib published in the New England Journal of Medicine
Results from the TOURMALINE-MM1 Phase 3 clinical study, published in the New England Journal of Medicine, have shown that oral ixazomib capsules in combination with lenalidomide and dexamethasone...
COPD: Sunovion Pharmaceuticals Inc. announces positive results from two Phase 3 clinical studies evaluating SUN-101/eFlow
Sunovion Pharmaceuticals Inc. (Sunovion) has announced positive results from the Phase 3 clinical trial program for SUN-101 (glycopyrrolate), a nebulized long-acting muscarinic antagonist (LAMA)...
Alizé Pharma reports positive results from its Phase II clinical trial of AZP-531 in Prader-Willi Syndrome
Results from the randomized, double blind and placebo-controlled Phase II trial show significant improvements in hyperphagia-related behavior, a key therapeutic objective in Prader-Willi Syndrome.
Medicare patients have low adherence to biologic drug therapy for psoriasis
About half of Medicare patients who start taking biologic therapies for moderate to severe plaque psoriasis stop within a year, according to a new study led by researchers from the Perelman School...
Multiple sclerosis: 10-year follow-up data on Lemtrada (alemtuzumab) presented at the AAN 2016 Annual Meeting
Sanofi Genzyme, the specialty care global business unit of Sanofi, has announced that a new long-term analysis detailing 10 years of clinical efficacy of Lemtrada® (alemtuzumab) in people with...
Are lab mice too cold? Why it matters for science
A typical mouse laboratory is kept between 20 and 26 degrees C, but if the mice had it their way, it would be a warm 30 degrees C.
Phase III data for nivolumab in head and neck cancer show biggest increase in survival for 20 years
Bristol-Myers Squibb has announced results from the pivotal CheckMate -141 Phase III clinical trial which showed that treatment with nivolumab, which is investigational in head and neck cancer...
Promising new data show nivolumab plus ipilimumab combination achieves unprecedented survival benefit in skin cancer
Bristol-Myers Squibb has announced the first overall survival results from CheckMate -069, a Phase II trial evaluating the investigational combination of nivolumab and ipilimumab vs.
New data shows benefits of Medtronic insulin pumps for people with type 2 diabetes
Medtronic plc has announced the publication of new data in Diabetes, Obesity and Metabolism from the continuation phase of the OpT2mise study, providing further clinical evidence in support of...
WindowsFlashQuicktime
Request Demo Reel DVD
Related Medical Animation Links

Copyright © 2016
Content Management / Website Design by Tresware